Tle3 as a marker for chemotherapy

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01) C12N 15/10 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2706881

Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer

La présente invention concerne des procédés d'utilisation de TLE3 comme marqueur pour prédire la probabilité qu'a le cancer d'un patient de répondre à une chimiothérapie. L'invention concerne également des procédés d'utilisation de TLE3 (transducin-like enhancer of split 3) comme marqueur pour sélectionner une chimiothérapie pour un cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tle3 as a marker for chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tle3 as a marker for chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tle3 as a marker for chemotherapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2072607

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.